Introduction
donors in order to transplant a sufficient number of insulin secreting cells, e.g. according to 48 our experience minimally 2 x 10 6 cells per kilogram of body weight [2] [3] [4] . Long-term in vitro 49 culture of islet grafts is, however, also associated to a variable degree of beta cell loss. 50
Optimization of culture conditions to minimize beta cell loss is currently hampered by the lack 51 of a specific and sensitive indicator of beta cell toxicity that can be used in high-throughput. 52
Here we describe the in vitro performance of a newly developed duplex immunoassay for two 53 protein-type indicators of beta cell injury. Specificity for beta cell-selective death was 54 5 as cells with damaged membranes whereas uptake of the highly polar dye PI is restricted to 100 cells with loss of plasma membrane potential, staining only dead cells. After 15 min of 101 incubation at 37°C with 5% CO 2 , cell viability was assessed both automatically (operator 102 independent) and manually (operator dependent). Absolute number of cells was determined 103
automatically by whole-well imaging using Pathway 435 (BD Biosciences, USA) ( Fig 1A) . 104
Acquisition of pictures using customer defined assays is done with Attovision software (BD 105 Biosciences, USA). After fine autofocus of Hoechst stained nuclei, a whole well montage of 8 106 by 12 pictures is taken from the Hoechst channel and from the PI -channel. Pictures are 107 analysed by Attovision software (BD Biosciences, USA); a signal threshold is set on 108 reference pictures made from each pictures by RB25 and "sharpened hat" algorithms. After 109 watershed, upper and lower limits are set to exclude debris and the number of viable and or 110 dead (PI+) cells is calculated for each well. 111
The cells were manually examined in an inverted fluorescence microscope with ultraviolet 112 excitation wavelength at 340-380 nm. Viable or necrotic cells were identified by intact nuclei 113 with, respectively, blue (Ho) or pink (Ho plus PI) fluorescence. Apoptotic cells were detected 114 by their fragmented nuclei which exhibited either a blue (Ho) or pink (Ho plus PI) 115 fluorescence depending on the stage in the process (Fig 1B) . In early apoptosis, only 116 Hoechst 33342 will reach the nuclear material, whilst in a later phase PI will also penetrate 117 the cells. In each condition and experiment, a minimum of 300 cells were counted. 118
Percentages of living, apoptotic, and necrotic cells were expressed as mean ± SD. 119
Detection of UCHL1 and GAD65

120
Detection antibodies
121
UCHL1 was detected by a sandwich antibody couple consisting of a capture antibody, 122 polyclonal goat anti-UCHL1 (Acris Antibodies, USA) raised against a peptide corresponding 123 to amino acids 58-68) and rabbit polyclonal anti-UCHL1 detection antibody (Atlas Antibodies,6 biotinylated using EZ Link™ NHS-Biotin (Thermo Fisher Scientific Inc., USA) according to 127 manufacturer's protocol. 128
Cytometric bead array (CBA)
129
The capture antibodies were covalently attached to CBA functional beads A4 and E7 (BD 130 Biosciences, USA) with sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate 131 chemistry according to manufacturer's protocol. Functionalized beads were stored shielded 132 from light at 4°C for no more than six months. Recombinant proteins were used to generate 133 standard curves and quality controls were stored in single use aliquots at -80°C providing 134 long-term stability (recombinant human UCHL1, Sigma Aldrich, USA and recombinant 135 human GAD65, Diamyd, Sweden). For a single measurement, 25 µL of sample (recombinant 136 standard material or supernatant sample) was mixed with 25 µL of Assay Diluent (BD 137
Biosciences, USA) and 20µL beads solution at 6000 beads per well in Capture Bead Diluent 138 (BD Biosciences, USA). This was incubated in a U-shaped 96-well predilution plate overnight 139 at 4°C, shaken and shielded from light. Hereafter, 20µL of a 5µg/mL solution of biotinylated 140 detection antibody for UCHL1 and GAD65 was added to all wells without prior washing. After 141 1 hour incubation at room temperature on the shaking plate, wells were transferred to 142
Multiscreen® filtration plate (Merck KGaA, Germany) and washed 6 times with 150 µl of 143 Wash Buffer (BD Biosciences, USA) using a Millipore Multiscreen (Perkin Elmer, USA) 144 adaptor, followed by addition of 100 µL of Human Enhanced Sensitivity Detection Reagent 145 (Part B) (BD Biosciences, USA). After incubation for one hour at room temperature, shaken 146 and shielded from light, wells were washed 6 times and content was transferred to 1. In vitro human islet transplant samples 165 Human islet cells were cultured for maximally 4 weeks in serum-free Ham's F10 medium and 166 characterized for beta cell number, endocrine purity and viability before selection for clinical 167 transplantation as described [4] . In this study, standardized islet grafts (n=14) sampled at the 168 time of intra-portal transplantation were cultured for 24 hours in 24 well plates with 500 µL 169 serum-free Ham's F10 medium. Subsequently, cells and medium were collected, centrifuged, 170 and supernatant from duplicate samples were combined. Human pancreatic islet graft 171 characteristics are described in Table 2 . 172
In vivo human islet transplant plasma samples
173
The UCHL1-GAD65 CBA assay was also applied to measure circulating UCHL1 and GAD65 174 concentrations after islet transplantation: non-uremic T1D patients typically received intra-175 portal infusion of at least 2.10 6 beta cells/kg bodyweight and plasma was sampled at various 176 time points before and up to 24 hours after transplantation. Plasma was collected in K3- 
Statistical analysis
210
Data were expressed as mean ± SD and p-values were calculated with Mann-Whitney U-test 211 using GraphPad Prism (GraphPad Software, USA). Statistical significance is denoted by 212 *p<0.05 and **p<0.0001. 213
Results
214
Imaging-based measurement of rat beta cell death in vitro 215 On day 0, 6000 single rat beta cells were seeded and exposed to two known inducers of 216 apoptotic beta cell death [9] , ER-stress inducer thapsigargin (0.2 µM) and a cocktail of pro-217 inflammatory cytokines: TNF-α+IL-1β+IFN-γ (all at 1ng/mL final concentration). Hydrogen 218 peroxide (H 2 O 2 ; 100µM final concentration), a potent oxidative inducer of necrotic rat beta 219 cell death was used as positive control [18] . Cell death and viability were measured after 3 220 and 6 days using an operator-dependent (manual) or -independent (semi-automated) 221 microscopic method. In the semi-automated method, a whole well image was generated 222 using a BD Pathway 435 platform as shown in Fig 1A, the total number of cells was counted 223 by integrating Hoechst-positive events and the number of dead, propidium-iodide positive 224 cells was calculated using BD Attovision software. These same wells were then subjected to 225 manual counting of percentage necrotic, apoptotic and living cells as indicated in Fig 1B and 6]. Here, we investigated if a newly developed enhanced-sensitivity bead-based duplex 245 assay for GAD65 and UCHL1 could also detect minor instances of apoptotic beta cell death 246 in vitro, taking the imaging-based methods (Fig. 1) as reference. UCHL1 came out as best 247 indicator: (i) Induced UCHL1 discharge by thapsigargin and cytokine-induced cell death was 248 consistently (P < 0.05) detected starting day 3. At this time point, GAD65 detected cytokine-249 but not thapsigargin-induced cell death (Fig. 2A); (ii) Stoichiometrically, extracellular UCHL1 250 was 20 times more abundant than GAD65; (iii) the molar amount of UCHL1 discharged 251 between day 3 and 6 showed an overall good agreement with the imaging-based increment 252 of cell death during this time frame (Fig. 2B) , while this was not the case for GAD65; (iv) 253 UCHL1, was discharged early during the incubation, as occurs during H 2 O 2 -induced 254 necrosis. It remained stable throughout the full 6 day incubation at 37°C while GAD65 255 showed 30 % degradation between day 3 and day 6. This is in line with its reported 256 thermolability [19] , and was also confirmed in a stability experiment in which GAD65 was 257 spiked in culture medium in absence of cells and maintained at 37°C for 3 days; this resulted 258 in only 19% recovery ( Supplementary Fig 1) . Overall, the discharged amounts of both 259 UCHL1 and GAD65 showed a significant (P<0.0001) linear correlation to the number of dead 260 beta cells, but expectedly this correlation was the strongest for UCHL1 (Fig. 2C) . 261 262 Analysis of biomarker recovery revealed, however, one anomaly for UCHL1: since 263 discharged UCHL1 is extracellularly stable (Fig. S1 and Fig. 2) , the amount of released 264 UCHL1 should be equivalent to the intracellular content of the disrupted beta cells. This was 265 not the case: for each K dead beta cell, 9.5 fmol UCHL1 was recovered from the medium, 266 well above the intracellular content measured by the same CBA-method in isolated cells 267 (Table 1 biomarker-based measurements represent a useful alternative. Therefore, we measured 280 UCHL1 and GAD65 discharge in vitro over 24h by standardized islet grafts (n=14) sampled 281 at the time of intra-portal transplantation, and studied statistical correlations to the graft 282 characteristics shown in Table 2 . The grafts showed a good overall viability and a low level of 283 contamination with exocrine acinar cells, as measured by electron microscopy, and 284 state-of-the-art endocrine purity (95%CI) with 31% (19-35)% insulin-positive cells. The 285 amount of UCHL1 discharged in vitro correlated significantly both to the total percentage of 286 dead cells, and to the number of beta cells. Also for GAD65, a correlation could be found 287 with the number of beta cells, but this correlation was less strong compared to UCHL1 and 288 was also seen with total cell number ( Table 2) . 289 clearance [5] . We tested the duplex UCHL1-GAD65 CBA assay in GAD65-autoantibody 295 negative islet graft recipients: while an acute plasma GAD65 surge could consistently be 296 detected, UCHL1 remained undetectable, both after the standard implantation in the liver 297 (Fig 3) , as after experimental implantation into the omentum, indicating that the superior in 298 vitro performance of UCHL1 as compared to GAD65 is not translated into clinical diagnostic 299 use. 300
301
Discussion and Conclusions
302
Here we report a novel method for in vitro analysis of rodent and human beta cell toxicity 303 using a sensitive duplex UCHL1-GAD65 CBA assay. The quantification of discharged beta 304 cell-biomarkers has several technical advantages for in vitro toxicological analysis of beta 305 cells, as compared to microscopic quantification of vital dyes or conventional tetrazolium dye-306 based (MTT) assays: (i) by targeting endocrine-restricted biomarkers, it can specifically 307 quantify beta cell injury in mixed cultures or impure islet fractions. It performs equally well in 308 adherent and suspension cultures, and unlike MTT, independently of the metabolic 309 phenotype of the cells; (ii) by using an enhanced-sensitivity bead-based immunoassay 310 approach [17] , it achieves sensitivities that could, in our hands, not be reached by MTT 311 assays on the small numbers of cells used in our experimental design, achieving even 312 superior sensitivity than the microscopic measurement of vital dyes; (iii) moreover, soluble 313 markers allow repeated sampling of the same wells and, unlike MTT and microscopy, does 314 not represent endpoint studies, thus allowing kinetic time-resolved analyses, and interim 315 sampling for quality control purposes, and finally (iv) the assay allows upscaling to high-316 throughput formats on widely available immunoassay platforms. 317
In vitro, UCHL1 appears superior to GAD65 as indicator of beta cell injury: UCHL1 showed a 318 better thermo-stability and outperformed GAD65 to detect early stages of beta cell apoptosis, 319 although its unexplained excessive immuno-recovery still necessitates the use of internal 320 controls. We repeatedly observed a 3-7 fold higher recovery of immuno-detectable UCHL1 321 than could be expected based on measurement of intracellular content. We hypothesize that 322 this behavior is explained by the loss of UCHL1 multimeric structure [23] after extracellular 323 discharge, inducing a higher accessibility of the UCHL1 epitopes targeted by our sandwich 324 immunoassay on the UCHL1 monomers. This behavior requires specific attention, since 325 UCHL1 is increasingly used in patients to quantify neuronal damage [23, 24] . UCHL1 is 326 reported as one of the most abundant proteins in neurons [23] . In human beta cells it ranks 327 among the higher-abundance core proteome detectable by LC-tandem MS [5, 25, 26] . Its 328 neuroendocrine-selectivity, combined with its high cellular abundance, favor the use of 329 UCHL1 as biomarker to detect neuronal or neuroendocrine cell death in vivo, Several groups 330 reported that intact UCHL1 protein can pass the blood brain barrier and become detectable 331 in the circulation after acute traumatic or ischemic brain injury [24] . Using our sandwich 332 immunoassay, we could detect beta cell-derived UCHL1 in the plasma after streptozotocin-333 induced synchronous and massive induction of beta cell necrosis in rats [5] . Here, we show 334 that despite its excellent in vitro behavior, the use of UCHL1 failed the translation to the 335 transplantation clinics. In human islet graft recipients, UCHL1 could not be detected after 336 intra-hepatic nor after intra-omental transplantation, although we expected detectable levels 337 as estimated by extrapolation of its in vitro discharge compared to GAD65. We hypothesizeits catalytic center. If the latter is true, this would also predict variability of immuno-detectable 341 UCHL1 in other models (e.g. traumatic brain injury), and caution in the use of UCHL1 as 342 quantitative indicator of neuroendocrine cell death. 343
In conclusion: the use of soluble biomarkers represents a fast, selective and sensitive 344 method for beta cell toxicity profiling in vitro. UCHL1 is superior to GAD65 in vitro but not in 345 (blue) and GAD65 (red) spiked in culture medium and stored at 37°C and 5%CO 2 for 3 to 6 388 days. 389
